Business · 13/11/2001
FDA Releases Draft Guidance on Assessing Reproductive Toxicities of Drugs
The Food and Drug Administration (FDA) has made available a draft guidance document that outlines a process for evaluating the potential human reproductive and developmental risks associated with drug exposure, when definitive human data is not available.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →